Gut microbes revealed as key players in liver disease solutions

In the editorial published on 4 September 2023, in the “gut-liver axis” special issue of the journal Hepatobiliary & Pancreatic Diseases International, Dr. Jian-Gao Fan and Dr. Lu Jiang from Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine provided a comprehensive elucidation of the pivotal role of gut microbiota in various liver diseases.

Optum’s biosimilar business to exclude brand-name Stelara, Humira in 2025

Optum Rx is moving into the biosimilar business with a company it’s calling Nuvaila, and it’s starting out with biosimilars to AbbVie’s blockbuster rheumatoid arthritis

September 11, 2024

H1 Expands Trial Landscape Platform with UK Diversity Data and AI-Powered Site Rescue

What You Should Know: – H1, a provider of healthcare data and analytics, has announced significant enhancements to its Trial Landscape platform. – These updates

October 31, 2024

Opinion | ‘Can Certainly Happen in Patients Who Are Not Surfers’: What We Heard This Week

“It can certainly happen in patients who are not surfers.” — Matthew Gorski, MD, of Northwell Health in Great Neck, New York, on the risk

August 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.